PharmaTher Announces Positive Topline Results from Clinical Study of Ketamine for Parkinson's Disease - GlobeNewswire

100% of patients treated with ketamine demonstrated reduction in dyskinesias as measured by the Unified Dyskinesia Rating Scale Ketamine was well......

100% of patients treated with ketamine demonstrated reduction in dyskinesias as measured by the Unified Dyskinesia Rating Scale Ketamine was well tolerated with no serious adverse events reported S… [+9391 chars]

full article...